Bococizumab

BIOLOGICAL2 trials

Sponsors

University of California, San Francisco, Pfizer

Conditions

Cardiovascular DiseaseDyslipidemiaPrimary Hyperlipidemia or Mixed Dyslipidemia

Phase 3

Bococizumab HIV Evaluation (B-HIVE) Study

TerminatedNCT02524106

University of California, San FranciscoCardiovascular Disease, Dyslipidemia

Start: 2016-08-31End: 2017-11-30Updated: 2019-06-19

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

WithdrawnNCT02947334

PfizerPrimary Hyperlipidemia or Mixed Dyslipidemia

Start: 2016-10-31End: 2019-05-03Updated: 2017-12-02